Telcoin Makes U.S. Banking History with Approval to Launch the First Regulated Digital Asset Bank
12.11.2025 19:00:00 CET | Business Wire | Press Release
Telcoin today announced its final charter approval from the Nebraska Department of Banking and Finance to launch Telcoin Digital Asset Bank, the first Digital Asset Depository Institution in the United States. The charter positions Telcoin to become the first true blockchain bank, directly connecting U.S. bank accounts to regulated “Digital Cash” stablecoins. Its flagship product, eUSD, will be the first bank-issued, on-chain U.S. dollar stablecoin, offering consumers and businesses a secure, compliant way to use Digital Cash for payments, remittances, and savings. Notably, it is also the first bank charter to explicitly authorize connecting U.S. consumers to DeFi.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112119122/en/
Telcoin’s eUSD and other global Digital Cash stablecoins represent an evolution of money that is programmable and interoperable, designed to move seamlessly across blockchain and traditional financial rails. Unlike unregulated, offshore, or non-bank stablecoins, eUSD is fully backed by U.S. dollar deposits and short-term Treasuries held in regulated reserves. Telcoin believes that the trust that comes with being regulated as a bank will drive consumer adoption as well as the institutional adoption needed to scale blockchain-powered finance to the broader market.
“Our charter makes history, and not just for Telcoin, but for the entire U.S. banking system,” said Paul Neuner, Telcoin’s Founder and CEO. “We’re proving that a bank can issue on-chain Digital Cash responsibly and operate in full alignment with U.S. regulators. eUSD brings the speed, transparency, and affordability of blockchain into everyday finance in a way that anyone can use.”
The approval coincides with the recent passage of the GENIUS Act, which provides long-awaited federal guidance for stablecoins and digital assets. While blockchain industry peers are seeking to operate as non-depository trust charters, Telcoin is providing a solution to the systemic risk concerns around stablecoins expressed by federal regulators.
“For us, this is not about stablecoins pulling money out of the banking system, but rather upgrading the technology of money, payments, and banking itself,” Neuner explains, adding that the bank’s native medium of transaction is a regulated, on-chain digital dollar directly connected to U.S. account numbers. More than just a stablecoin issuer, the bank plans to provide compliant stablecoin yield offerings along with a suite of retail and commercial depository services, subject to regulatory approval.
Telcoin Digital Asset Bank also intends to help community banks nationwide adapt to the evolving technology. “There are almost 5,000 banks in the U.S., and only the largest five percent of them will be able to do digital assets in-house,” said Patrick Gerhart, President of Banking Operations at Telcoin. “We look forward to helping the other 95 percent of U.S. banks stay relevant and connect to blockchain-based finance in a safe and sound manner.”
By aligning digital assets within a regulated banking framework, Telcoin Digital Asset Bank bridges the $4 trillion blockchain economy with traditional finance to unlock this technology for modern money, capital markets, and finance on the internet. This model demonstrates how Digital Cash can strengthen community bank balance sheets, empower small businesses, and modernize payments at scale, setting a new standard for how blockchain and banking can work together.
“We’ve been working toward this landmark for years, and now Telcoin Digital Asset Bank gets to serve as a prime example for how both compliance and innovation can work together to elevate the standard of banking,” adds Neuner. “On a global stage, Telcoin will demonstrate how local institutions, national regulators, and international innovators can move together to make money flow at the speed of the internet.”
Governor Jim Pillen signed the charter at the Nebraska State Capitol in Lincoln today, where the Nebraska Financial Innovation Act became law in 2021. That initiative, spearheaded by former Nebraska Speaker and current U.S. Congressman Mike Flood, laid the foundation for today’s charter issuance. Nebraska Department of Banking and Finance Director Kelly Lammers was also instrumental in developing the Digital Asset Depository Institution charter from the NFIA, placing Nebraska at the center of the national landscape for blockchain banking innovation.
ABOUT TELCOIN
Telcoin, a multinational fintech serving 171 countries, is revolutionizing global finance by merging blockchain technology, telecommunications, and banking. Telcoin Digital Asset Bank is a Digital Asset Depository Institution in establishment under charter from the Nebraska Department of Banking and Finance. It will issue eUSD, the first regulated, bank-issued U.S. dollar stablecoin. Telcoin offers secure, self-custodial blockchain payments and banking services globally, powered by its own decentralized financial infrastructure. This compliant, banking-first approach harnesses blockchain's power to redefine how the world interacts with money on the internet. Learn more at www.telco.in.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251112119122/en/
Contacts
MEDIA CONTACT
Janelle Burdette Redden
janelle@scrib3.co
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom